Source - LSE Non-Regulatory
RNS Number : 3078S
Ergomed plc
15 November 2021
 

 PRESS RELEASE

 

 

Ergomed to Present at Jefferies London Healthcare Conference 2021

 

 

Guildford, UK - 15 November 2021: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing specialised services to the pharmaceutical industry, today announces that Dr Miroslav Reljanović, Executive Chairman of Ergomed, will present at the Jefferies London Healthcare Conference at 8am GMT on 16 November 2021.

 

The presentation will be available on Ergomed's website, here:

https://ergomedplc.com/news-and-events/

 

 

ENDS

 

Enquiries:

 

Ergomed plc                                                                           Tel: +44 (0) 1483 402 975

Dr Miroslav Reljanović (Executive Chairman)      

Richard Barfield (Chief Financial Officer)           

           

Numis Securities Limited                                                         Tel: +44 (0) 20 7260 1000

Freddie Barnfield / Matthew O'Dowd (Nominated Adviser)          

James Black (Broker)   

 

Peel Hunt LLP                                                                          Tel: +44 (0) 20 7418 8900

James Steel / Dr Christopher Golden

           

Consilium Strategic Communications                                      Tel: +44 (0) 20 3709 5700

Chris Gardner / Matthew Neal                                                     ergomed@consilium-comms.com

Angela Gray

 

 

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO). For further information, visit: http://ergomedplc.com.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGPGRWGUPGGBC
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.